Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Amortizatization of Intangibles (2018 - 2022)

Historic Amortizatization of Intangibles for TransMedics (TMDX) over the last 5 years, with Q3 2022 value amounting to $12000.0.

  • TransMedics' Amortizatization of Intangibles fell 9610.39% to $12000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $381000.0, marking a year-over-year decrease of 7190.27%. This contributed to the annual value of $381000.0 for FY2022, which is 7190.27% down from last year.
  • According to the latest figures from Q3 2022, TransMedics' Amortizatization of Intangibles is $12000.0, which was down 9610.39% from $141000.0 recorded in Q2 2022.
  • In the past 5 years, TransMedics' Amortizatization of Intangibles ranged from a high of $391000.0 in Q1 2021 and a low of -$112000.0 during Q3 2019
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $184500.0 (2022), whereas its average is $157071.4.
  • Per our database at Business Quant, TransMedics' Amortizatization of Intangibles skyrocketed by 3900000.0% in 2021 and then plummeted by 9610.39% in 2022.
  • Quarter analysis of 5 years shows TransMedics' Amortizatization of Intangibles stood at $9000.0 in 2018, then plummeted by 866.67% to -$69000.0 in 2019, then skyrocketed by 578.26% to $330000.0 in 2020, then fell by 14.85% to $281000.0 in 2021, then tumbled by 95.73% to $12000.0 in 2022.
  • Its Amortizatization of Intangibles was $12000.0 in Q3 2022, compared to $141000.0 in Q2 2022 and $228000.0 in Q1 2022.